全文获取类型
收费全文 | 299篇 |
免费 | 17篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 19篇 |
妇产科学 | 2篇 |
基础医学 | 45篇 |
口腔科学 | 10篇 |
临床医学 | 44篇 |
内科学 | 66篇 |
皮肤病学 | 3篇 |
神经病学 | 43篇 |
特种医学 | 52篇 |
外科学 | 17篇 |
综合类 | 16篇 |
预防医学 | 7篇 |
眼科学 | 3篇 |
药学 | 21篇 |
中国医学 | 1篇 |
肿瘤学 | 7篇 |
出版年
2019年 | 1篇 |
2018年 | 1篇 |
2017年 | 6篇 |
2016年 | 3篇 |
2015年 | 10篇 |
2014年 | 5篇 |
2013年 | 16篇 |
2012年 | 5篇 |
2011年 | 7篇 |
2010年 | 12篇 |
2009年 | 13篇 |
2008年 | 5篇 |
2007年 | 30篇 |
2006年 | 8篇 |
2005年 | 13篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 3篇 |
2001年 | 3篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1998年 | 14篇 |
1997年 | 29篇 |
1996年 | 20篇 |
1995年 | 7篇 |
1994年 | 10篇 |
1993年 | 7篇 |
1992年 | 3篇 |
1991年 | 5篇 |
1989年 | 12篇 |
1988年 | 8篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 6篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 7篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 1篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有357条查询结果,搜索用时 187 毫秒
291.
BACKGROUND: The aim of this study was to determine the frequency and origin of additional alloantibodies directed against red cells (RBCs) after intrauterine transfusion (IUT). STUDY DESIGN AND METHODS: Between March 1987 and December 1992, fetuses with severe hemolytic disease (n = 91) received a total of 280 ultrasound-guided IUTs of RBCs from unrelated donors. The specificity of alloantibodies to RBCs in maternal serum was determined both before and after each IUT. If additional alloantibodies directed against RBCs were detected, their origin was determined by phenotyping the fetal, donor, and paternal RBCs for each particular antigen. The study included a control group of 69 pregnant women who underwent either amniocentesis or fetal blood sampling. RESULTS: Production of additional alloantibodies directed against RBC antigens was detected in 24 women (26%). The source of the immunizing antigen, either donor or fetus, was identified in 14 patients. The additional alloantibodies were directed against fetal antigens in 11 women and against donor antigens in 3. One additional alloantibody directed against donor antigen clearly reduced the survival of donor RBCs. The fetus and the donor shared the immunizing antigen in four cases, and in one case, the antibody occurred naturally. In five cases, the source of the immunizing antigen was not determined. In the control group, additional antibodies were detected in two patients. CONCLUSION: IUT therapy is associated with a high incidence of additional alloantibodies. In the majority of patients, the use of maternal RBCs for IUT would not have prevented additional formation of alloantibody to RBCs. 相似文献
292.
The release of secretory phospholipase A2 (sPLA2) into the mammalian circulation may contribute to the development of hemorrhagic and inflammatory diseases. sPLA2 has previously been shown to alter the behavior of platelets, leukocytes, and endothelial cells, although the molecular basis for these cellular effects has not been established. Our studies indicate that the inhibition of platelet aggregation by snake, bee venom, and pancreatic sPLA2 is dependent on a plasma cofactor. This cofactor resides within the lipoprotein fraction of plasma, with 54%, 31%, and 11% of the activity present in the high- density lipoprotein (HDL), low-density lipoprotein (LDL), and very low density lipoprotein (VLDL) fractions, respectively. Delipidation of HDL and LDL was associated with the complete loss of platelet-inhibitory activity. Incubation of purified sPLA2 with the HDL fraction of plasma resulted in the time-dependent generation of lysophosphatidylcholine (lysoPC). The formation of lysoPC correlated with the inhibition of platelet aggregation. Purified lysoPC (10 to 100 micrograms/mL) inhibited platelet aggregation and dense granule release induced by thrombin (0.05 U/mL), collagen (1 micrograms/mL), ionophore A23187 (2 mumol/L), ADP (12.5 mumol/L), and adrenaline (3.2 mumol/L). The inhibition of platelet aggregation by lysoPC was dose-dependent and correlated with decreased fibrinogen binding to glycoprotein IIb-IIIa. Our studies indicate that the enzymatic generation of lysoPC from plasma lipoproteins is essential for the sPLA2-mediated inhibition of platelet activation in the presence of albumin. These results raise the possibility that the toxic effects of circulating sPLA2 may be due in part to the generation of the bioactive lysophospholipid, lysoPC. 相似文献
293.
Kuper HH; van Leeuwen MA; van Riel PL; Prevoo ML; Houtman PM; Lolkema WF; van Rijswijk MH 《Rheumatology (Oxford, England)》1997,36(8):855-860
An assessment of the onset of radiographic damage in the large joints (hip,
knees, shoulders, elbows, ankles and tarsus) in patients with early
rheumatoid arthritis, and the relationship of the progression of large
joint damage with joint damage in hands and feet, with physical disability,
and with cumulative disease activity, was performed in a prospective 6 yr
follow-up study. Large joint damage appeared to be an early phenomenon with
20% of the patients having some damage in at least one large joint within 1
yr, and 50% of the patients within 6 yr after disease onset. Radiographic
damage in large joints was significantly related to the damage in hands and
feet, the physical disability index, and the cumulative disease activity.
The initial disease activity at study entry was the only prognostic factor
that reached significance.
相似文献
294.
Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis 总被引:6,自引:2,他引:6
Ronday HK; Smits HH; Quax PH; van der Pluijm G; Lowik CW; Breedveld FC; Verheijen JH 《Rheumatology (Oxford, England)》1997,36(1):9-15
The observed increase in urokinase-type plasminogen activator (u-PA) and
its receptor (u-PAR) in synovial tissue of patients with rheumatoid
arthritis (RA) suggests pathophysiological involvement of the plasminogen
activation (PA) system in inflammatory joint disease. In the present study,
we investigated the capacity of the PA system to degrade non-mineralized
and mineralized bone-like matrix in vitro as a model for bone destruction.
Transfected mouse LB6 cell lines, that expressed either human u-PA or
u-PAR, were cultured separately and simultaneously on radiolabelled bone
matrix in the presence of plasminogen. Osteoblast-like murine calvarial
MC3T3-E1 cells were used to produce a well-characterized, highly organized
bone-like matrix, that could be mineralized in the presence of
beta-glycerol phosphate. Bone matrix degradation was followed by the
release of radioactivity in the culture medium. u-PA-producing cells, in
contrast to u-PAR- producing cells, degraded both non-mineralized and
mineralized bone matrix. This effect could be inhibited by anti-u-PA
antibodies, as well as by tranexamic acid and by aprotinin, indicating that
the degrading activity is u-PA mediated and plasmin dependent.
Co-cultivation of a small portion of u-PA-producing cells with
u-PAR-expressing cells resulted in a marked increase in degradation
activity. Reduction of this potentiating effect by suramin or the
amino-terminal fragment of u- PA, both competitive inhibitors of u-PA
receptor binding, shows that this synergistic effect is due to binding of
u-PA to u-PAR. u-PAR must be cell associated, as binding of u-PA to a
soluble u-PAR prevented this enhancement. The capability of the PA system
to degrade bone matrix in vitro, and the previously demonstrated increased
expression of u-PA and u-PAR in synovial tissue of patients with RA,
further support a role for the PA system in the development of bone
erosions.
相似文献
295.
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study 总被引:8,自引:4,他引:8
Antonarakis SE; Rossiter JP; Young M; Horst J; de Moerloose P; Sommer SS; Ketterling RP; Kazazian HH Jr; Negrier C; Vinciguerra C 《Blood》1995,86(6):2206-2212
Twenty-two molecular diagnostic laboratories from 14 countries participated in a consortium study to estimate the impact of Factor VIII gene inversions in severe hemophilia A. A total of 2,093 patients with severe hemophilia A were studied; of those, 740 (35%) had a type 1 (distal) factor VIII inversion, and 140 (7%) showed a type 2 (proximal) inversion. In 25 cases, the molecular analysis showed additional abnormal or polymorphic patterns. Ninety-eight percent of 532 mothers of patients with inversions were carriers of the abnormal factor VIII gene; when only mothers of nonfamilial cases were studied, 9 de novo inversions in maternal germ cells were observed among 225 cases (approximately 1 de novo maternal origin of the inversion in 25 mothers of sporadic cases). When the maternal grandparental origin was examined, the inversions occurred de novo in male germ cells in 69 cases and female germ cells in 1 case. The presence of factor VIII inversions is not a major predisposing factor for the development of factor VIII inhibitors; however, slightly more patients with severe hemophilia A and factor VIII inversions develop inhibitors (130 of 642 [20%]) than patients with severe hemophilia A without inversions (131 of 821 [16%]). 相似文献
296.
Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cells 总被引:3,自引:0,他引:3
A new monoclonal antibody Ki-B3 produced by a fusion with leukemic cells of a centroblastic/centrocytic lymphoma (m.l. follicular) is introduced. This antibody predominantly recognizes B cells of follicular mantle and germinal center cells, as well as plasma cells in normal lymphoid tissue. Furthermore, 80% of all low- and high-grade B cell lymphomas are stained, whereas among T cell lymphomas, only four of 15 T lymphoblastic lymphomas were positive to Ki-B3. All peripheral T cell lymphomas showed a negative reaction. Additionally, Ki-B3 detects a small percentage of monocytes and some myelomonocytic leukemias. All epithelial tissues as well as all sarcomas tested were invariably negative. Ki-B3 precipitates a 220 kiloDalton (kD) molecular weight antigen similar to the leukocyte common antigen. Presumably Ki- B3 detects a subtype of the leukocyte common antigen that is predominantly expressed on mature and immature B cells. As the antigen is formalin resistant, Ki-B3 can be used in routine hematology on paraffin sections for the detection and differential diagnosis of B cell lymphomas. 相似文献
297.
Prenatal diagnosis of beta-thalassemias by amniocentesis: linkage analysis using multiple polymorphic restriction endonuclease sites 总被引:10,自引:0,他引:10
In order to assess the applicability of multiple restriction endonuclease analyses of amniocyte DNA to the prenatal diagnosis of beta-thalassemias in general, we studied 12 consecutive couples at risk. DNA of both members of the 12 couples and a previous offspring of each was analyzed for the presence of 4 polymorphic restriction endonuclease sites: the Hpa I site 3' to the beta-globin gene, the Hind III site in the G gamma gene, the Hind III site in the A gamma gene, and the Bam HI site 3' to the beta-gene. Linkage disequilibrium between these sites and beta A or beta thal genes was not found, presumably due to the heterogeneity of beta thal genes. However, the high frequency of polymorphism at these sites allowed differentiation of beta A-bearing chromosomes from beta thal or beta S-bearing chromosomes in both members of 6 couples. In these couples, complete prenatal diagnosis by linkage analysis of amniocyte DNA would be possible. In the remaining 6 couples, beta A and beta thal chromosomes could be discriminated in one member. In about 50% of the pregnancies of these couples, exclusion of beta-thalassemia is possible by this analysis. These data suggest that when linkage analysis of polymorphic restriction endonuclease sites is carried out, prenatal diagnosis of beta-thalassemia states can be accomplished by amniocentesis alone in 75% of pregnancies at risk. 相似文献
298.
Bergeron RJ; Streiff RR; Creary EA; Daniels RD Jr; King W; Luchetta G; Wiegand J; Moerker T; Peter HH 《Blood》1993,81(8):2166-2173
A comparative study of the iron-clearing properties of subcutaneously administered desferrioxamine B (DFO) with those of orally administered desferrithiocin sodium salt (1), desmethyl desferrithiocin (2), desazadesmethyl desferrithiocin sodium salt (3), desazadesmethyl desferrithiocin pivaloyloxymethyl ester (4), and desazadesmethyl-5,5- dimethyl desferrithiocin (5) in an iron-loaded Cebus monkey model and a non-iron overloaded bile duct-cannulated rat model is presented. All six drugs, which performed well in rodent studies, demonstrated increased efficiency in the Cebus monkey model. When administered to rodents at a daily dosage of 384 mumol/kg over a period of 10 days, drug 1 demonstrated severe renal toxicity. whereas drugs 3, 4, and 5 exhibited severe gastrointestinal (GI) toxicity. Under the same experimental protocol, drug 2 did not show significant toxic side effects. In addition, to further evaluate the iron-clearing properties of analogue 2, a dose-response study was performed in the primates that showed that iron excretion increased in a dose-dependent fashion. 相似文献
299.
Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome 总被引:9,自引:0,他引:9
Altered polymorphonuclear leukocyte (PMN) function is thought to contribute to organ dysfunction during the systemic inflammatory response syndrome (SIRS). To test this hypothesis, we evaluated whole blood PMN function adherent to fibronectin or laminin in patients with mild or severe acute pancreatitis as a paradigm for sirs. Whole-blood PMN intracellular H2O2 production, expression of CD32w (Fc gamma R II), CD16 (Fc gamma R III), and phagocytosis were performed using dichlorofluorescein diacetate, fluorescein isothiocyanate-labeled anti- CD32w, CD16, and serum-opsonized fluorescent microspheres. Group I (n x 7) represents normal control individuals; group II (n x 11) represents patients with mild acute pancreatitis. Group III (n x 15) represents critically ill patients with severe acute pancreatitis. Adherence of PMN from groups I and II to matrix proteins resulted in a 5% to 20% increase in each PMN function assayed whereas adherence of PMN from group III to matrix proteins resulted in 50% to 75% increases in each PMN function assayed. Pertussis toxin, pentoxifylline, and dibutyryl cyclic adenosine monophosphate (cAMP) each reduced group I-II H2O2 production and phagocytosis. Pentoxifylline and dibutyryl cAMP but not pertussis toxin reduced group III H2O2 production. Both intracellular H2O2 and phagocytosis assays from group III but not groups I-II showed exaggerated upregulation when exposed to NaF (4 mmol/L). Anti- interleukin-6 reduced the increase in intracellular H2O2 production in group III patients and significantly altered the exaggerated oxidative response to NaF. Longitudinal studies of group III whole-blood PMN showed persistent upregulation of intracellular H2O2 production in those patients whose hospital courses were complicated by multiple system organ failure. These results demonstrate abnormal whole blood PMN function during the systemic inflammatory response syndrome in the presence of fibronectin, or laminin and that this is mediated in part via a pertussis toxin insensitive altered guanosine triphosphate- binding protein. 相似文献
300.
To make possible prenatal diagnosis of beta-thalassemia in China and Southeast Asia by direct detection of mutant beta-globin genes, we have determined the spectrum of mutations producing the disorder in this region of the world. Seventy-eight beta-thalassemia genes from Chinese and Southeast Asians were randomly obtained, and the relevant mutation was characterized in 76 (98%) of them. Seven different point mutations were found among the 78 genes studied. Of these seven beta-thalassemia alleles, two constitute 62%, and two others account for 29% of the total. Since only four alleles make up 91% of the mutant genes, prenatal diagnosis of beta-thalassemia in China and Southeast Asia should be feasible by simplified techniques for direct detection of point mutations. 相似文献